Pomelo Care vs ResMed
Side-by-side comparison of AI visibility scores, market position, and capabilities
Pomelo Care hit $1.7B unicorn ($92M Series C, Jan 2026) covering ~7% of US births (25M+ lives) with peer-reviewed results: 37% fewer preterm births, 46% lower ER utilization.
About
Pomelo Care is a New York-based virtual maternity and women's health company that raised $92 million in Series C funding in January 2026, reaching a $1.7 billion unicorn valuation. The round was led by Stripes with participation from Andreessen Horowitz, PLUS Capital, Atomico, BoxGroup, and SV Angel. Founded in 2021, Pomelo now supports nearly 7 percent of all U.S. births.
ResMed (RMD) reported ~$4.7B revenue in FY2024. Global leader in cloud-connected devices for sleep apnea, COPD, and out-of-hospital care, with 10M+ connected devices. HQ: San Diego.
About
ResMed Inc. is the global leader in cloud-connected medical devices and software for diagnosing and treating sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions in out-of-hospital settings. Founded in Sydney, Australia in 1989, the company designs and manufactures CPAP (continuous positive airway pressure) machines, masks, ventilators, and related accessories used by patients with obstructive sleep apnea — a condition affecting approximately 1 billion people globally that is chronically under-diagnosed and under-treated.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.